Navigation Links
Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases
Date:7/7/2009

THOUSAND OAKS, Calif., July 7 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced that a pivotal, Phase 3, head-to-head trial evaluating denosumab versus Zometa(R) (zoledronic acid) in the treatment of bone metastases in 2,049 patients with advanced breast cancer met its primary and secondary endpoints and demonstrated superior efficacy compared to Zometa. Superiority was demonstrated for both delaying the time to the first on-study Skeletal Related Events (SREs)(fracture, radiation to bone, surgery to bone, or spinal cord compression) (hazard ratio 0.82, 95 percent CI: 0.71, 0.95), and delaying the time to the first-and-subsequent SREs (hazard ratio 0.77, 95 percent CI: 0.66, 0.89). Both results were statistically significant.

Overall, the incidence of adverse events and serious adverse events was consistent with what has previously been reported for these two agents. Of note, osteonecrosis of the jaw (ONJ), which had not been observed in previously reported Phase 3 studies with denosumab, was seen infrequently in both treatment groups. There was no statistically significant difference in the rate of ONJ between the two treatment arms. Infectious adverse events were balanced between the two treatment arms, as was overall survival and the time to cancer progression.

"We are extremely pleased with the outcome of this important study, which shows that denosumab can reduce or delay the serious complications of bone metastases in breast cancer patients better than the current standard of care, and with a favorable benefit/risk profile," said Roger M. Perlmutter, M.D., Ph.D., executive vice president of Research and Development at Amgen. "These results underscore the importance of the RANK Ligand pathway in bone disease, and offer the promise of improved care for patients with advanced breast cancer. We look forward to
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Thiarabine Demonstrates a Reduction of Both Inflammatory and Erosive Disease Parameters in Rheumatoid Arthritis
2. Vantia Therapeutics Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia
3. Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)
4. Study Demonstrates Efficacy of Pitavastatin in Elderly Patients
5. Semafores SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients
6. Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
7. Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen
8. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
9. Study Demonstrates Restylane(R) Effect Lasted 18 Months in 97% of Patients With One Repeat Injection
10. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
11. Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... 3, 2015 Discovery Laboratories, Inc. (Nasdaq: ... on developing aerosolized KL4 surfactant therapies for respiratory ... at 8:30 a.m. Eastern Time on Tuesday August 11, ... 2015 second quarter financial results along with providing ... press release announcing the second quarter 2015 financial ...
(Date:8/3/2015)... Aug. 3, 2015 Diplomat Pharmacy, Inc. (NYSE: ... results for the quarter ended June 30, 2015. All comparisons, ... 2014. Second Quarter 2015 Highlights include: ... or $266 million , Total prescriptions dispensed of 234,000, ... versus 5.5% , Adjusted EBITDA of $22.7 million, an ...
(Date:8/3/2015)... CHESTNUT RIDGE, N.Y. , Aug. 3, 2015 /PRNewswire/ ... will host a conference call on Friday, August 7, ... of operations for the second quarter ended June 30, ... financial information available to the public in its filings ... certain other information available on its website by following ...
Breaking Medicine Technology:Discovery Labs to Hold Conference Call on Tuesday August 11, 2015 to Discuss Second Quarter 2015 Financial Results and Other Business Updates 2Diplomat Announces 2nd Quarter 2015 Financial Results 2Diplomat Announces 2nd Quarter 2015 Financial Results 3Diplomat Announces 2nd Quarter 2015 Financial Results 4Diplomat Announces 2nd Quarter 2015 Financial Results 5Diplomat Announces 2nd Quarter 2015 Financial Results 6Diplomat Announces 2nd Quarter 2015 Financial Results 7Diplomat Announces 2nd Quarter 2015 Financial Results 8Diplomat Announces 2nd Quarter 2015 Financial Results 9Diplomat Announces 2nd Quarter 2015 Financial Results 10Diplomat Announces 2nd Quarter 2015 Financial Results 11Diplomat Announces 2nd Quarter 2015 Financial Results 12Diplomat Announces 2nd Quarter 2015 Financial Results 13Diplomat Announces 2nd Quarter 2015 Financial Results 14Diplomat Announces 2nd Quarter 2015 Financial Results 15Diplomat Announces 2nd Quarter 2015 Financial Results 16Diplomat Announces 2nd Quarter 2015 Financial Results 17Diplomat Announces 2nd Quarter 2015 Financial Results 18
... Jan. 18, 2011 BNY Mellon and The SSI Group, ... of the alliance between the two companies, SSI,s health care ... bill payment capabilities.   Under this agreement, health ... button to the screens they use in interacting with SSI,s ...
... AUSTIN, Texas, Jan. 18, 2011 Hanger Orthopedic Group, Inc. (NYSE: ... its results of operations for the quarter ended December 31, 2010, ... issue a press release announcing the results for the quarter ended ... February 9, 2011 after the close of the market. A conference ...
Cached Medicine Technology:The SSI Group to Provide Health Care Providers with BNY Mellon's Electronic Payment Solutions 2The SSI Group to Provide Health Care Providers with BNY Mellon's Electronic Payment Solutions 3Hanger Orthopedic Group, Inc. Announces Fourth Quarter 2010 Earnings Release Conference Call 2
(Date:8/3/2015)... ... 2015 , ... Approved provider of Florida Physical Therapy ... for the month of August. , Physical therapy professionals in Florida can register ... Physical Therapy Flex package. Flex packages allow therapists to combine best selling text, ...
(Date:8/3/2015)... Indiana (PRWEB) , ... August 03, 2015 , ... ... throughout Livingston and Putnam counties. As a family owned and operated business, ... septic matters. They are a leader in septic installations because of their ...
(Date:8/3/2015)... ... August 03, 2015 , ... Since 1978, the number of black males ... new publication released today by the AAMC (Association of American Medical Colleges). , ... past three decades, the number of black male applicants to medical school dropped to ...
(Date:8/3/2015)... ... August 03, 2015 , ... According to an opinion piece published July 28 by ... to one pound of weight loss may not be accurate. While this system may work ... pound of fat varies – based both on the individual and at what point that ...
(Date:8/3/2015)... , ... August 03, 2015 , ... ... in 2015 MarketingProfs Bright Bulb B2B Awards. , The MarketingProfs Bright Bulb B2B ... B2B brands. BESLER Consulting's campaign for the launch of their Readmissions Analytics product ...
Breaking Medicine News(10 mins):Health News:Elite Online CE Provider Announces Schedule of Live Courses For Florida Physical Therapy Continuing Education 2Health News:Elite Online CE Provider Announces Schedule of Live Courses For Florida Physical Therapy Continuing Education 3Health News:Zeiter’s Septics Performs Affordable Septic Installations Throughout Livingston & Putnam Counties Effective Immediately 2Health News:Zeiter’s Septics Performs Affordable Septic Installations Throughout Livingston & Putnam Counties Effective Immediately 3Health News:New Publication Focuses on the Decline of Black Males in Medicine 2Health News:New Publication Focuses on the Decline of Black Males in Medicine 3Health News:New Publication Focuses on the Decline of Black Males in Medicine 4Health News:Article Dispelling Weight Loss Myth Correctly Emphasizes the Complicated and Difficult Nature of Weight Loss, Says Dr. Michael Feiz 2
... the Australian Institute of Health and Welfare (AIHW) has found ... heart attacks and cardiovascular disease at rates that are higher ... researchers have also reported in their study that people in ... hospital for the disease. The researchers have explained that their ...
... Roy Thayer’s underwent an emergency life saving operation by writing a ... was reported that Roy, 77, was warned that the long wait ... knew that there was no way he could afford to pay ... the operation at a private hospital, knowing fully well that by ...
... well into childhood long after children are weaned according ... revealed that breast-fed children cope better with stressful situations ... ,Dr Scott Montgomery, an epidemiologist at the Karolinska ... there is less of an association between parental divorce ...
... forum on HIV/AIDS for the UN will be among ... from Aug 13. // ,"Canada is eager ... disparities in access to HIV treatment throughout the world," ... the McGill University AIDS Center. ,The biennial ...
... cancer-fighting properties of tulsi, which is grown in many Indian ... 10 students at the University of Rajasthan.// ,"We arrived ... said Ashok Sharma, who heads the research project. ... IANS. The rats were first divided into two groups and ...
... sudden, worsening chest pain or a certain type of ... invasive treatment// rather than being treated conservatively, a new ... evidence suggests that an early invasive strategy is superior ... of the Centre for Research in Vascular Biology at ...
Cached Medicine News:Health News:Wily Old Man Undergoes A life Saving Operation With A Worthless Cheque 2Health News:Childhood Anxiety Reduced with Breast-feeding 2Health News:Indian to Conduct Workshop at Global AIDS Meet 2Health News:Emergency Heart Patients Do Better With Invasive Approach 2Health News:Emergency Heart Patients Do Better With Invasive Approach 3Health News:Emergency Heart Patients Do Better With Invasive Approach 4
The Arrow 2 Fr. QuadPolar electrode catheter and triple lumen guide system is designed for faster and easier electrophysiology studies. The 2 Fr. QuadPolar catheter is highly torqueable, radiopaque, ...
... Triad Skull Clamp, compatible with the full ... of clamping force on all three skull ... the possibility of adjusting the force on ... be increased or decreased by adjusting the ...
... albumin, creatinine and albumin-to-creatinine ratio results in ... useful to test for microalbuminuria in patients ... detect early kidney disease. , ,Microalbuminuria, ... excretion rate, is an indicator of organ ...
A fully automated, benchtop instrument designed for high-volume urine testing, using Siemens' proven technology in dry-pad urine chemistry analysis....
Medicine Products: